Clinical Trial Update: Effect of Addition of Dexmedetomidine or Ketamine to Intravenous Infusion of Lidocaine on Proinflammatory Cytokines in Pelvi-abdominal Cancer Surgeries. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial completed to evaluate whether adding dexmedetomidine or ketamine to an intravenous lidocaine infusion modulates proinflammatory cytokines…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Cancer
• Pelvic Cancer

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Ketamine (ketamine)
• Lidocaine (Lidocaine)

Snippet

Sponsor: Alexandria University | Conditions: Pelvic Cancer, Abdominal Cancer | Phase 1 | Status: COMPLETED